Read More

EXCLUSIVE: Medical Marijuana, Inc. Subsidiary HempMeds Working With Argentine Research Hospital On CBD For Adult Epilepsy

Medical Marijuana, Inc. (OTC: MJNA), the first publicly-traded cannabis company to launch cannabis-derived nutraceutical products, brands, and supply chains announced that its subsidiary HempMeds is collaborating with Hospital del Cruce to conduct a study in Argentina on the efficiency of CBD

MJNA

Read More

Affordable Housing, Less Carbon: DOE Funds Texas A&M University 3D-Printed Hempcrete Project

The Department of Energy (DOE) has awarded Texas A&M University $3.47 million to support a project to 3D print a bio-aggregate composite consisting of hemp hurd and a lime-based binder, also known as hempcrete, a material with the potential to lower the environmental impact of traditional construction and make housing more affordable and available,

OWPC

Read More

Meet Alvaro Torres, CEO Of Lat Am & UK’s Top Medical Marijuana Brand At Benzinga’s Cannabis Capital Conference In September

After a prosperous Miami event this past April, the Benzinga Cannabis Capital Conference will take place in Chicago on September 13-14. As always, the meeting will host leading executives and investors who will talk about the industry’s present and future.

KHRNF

Read More

Cannabis Goes Head-to-Head With Big Pharma In New Zelira Therapeutics Pain Med Study

Zelira Therapeutics (OTC: ZLDAF), a global leader in the research, development and commercialization of clinically validated cannabinoid medicines, is about to begin a first-ever clinical trial of its own proprietary pain formula for the treatment of diabetic nerve pain against an as-y

ZLDAF